Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa

NCT02696902 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT02696902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02696902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa
Lead sponsor
MedImmune LLC
Phase
Phase 2
Overall status
Completed
Start date
March 25, 2016
Completion date
December 4, 2019
Enrollment
188 (actual)
Sites
78

Conditions

As the registry lists them; a condition with its own page is linked.

pseudomonas aeruginosa